VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.
Fiche publication
Date publication
décembre 2014
Journal
Nature neuroscience
Auteurs
Membres identifiés du Cancéropôle Est :
Mme KOEBEL Pascale
Tous les auteurs :
Grieder TE, Herman MA, Contet C, Tan LA, Vargas-Perez H, Cohen A, Chwalek M, Maal-Bared G, Freiling J, Schlosburg JE, Clarke L, Crawford E, Koebel P, Repunte-Canonigo V, Sanna PP, Tapper AR, Roberto M, Kieffer BL, Sawchenko PE, Koob GF, van der Kooy D, George O
Lien Pubmed
Résumé
Dopaminergic neurons in the ventral tegmental area (VTA) are well known for mediating the positive reinforcing effects of drugs of abuse. Here we identify in rodents and humans a population of VTA dopaminergic neurons expressing corticotropin-releasing factor (CRF). We provide further evidence in rodents that chronic nicotine exposure upregulates Crh mRNA (encoding CRF) in dopaminergic neurons of the posterior VTA, activates local CRF1 receptors and blocks nicotine-induced activation of transient GABAergic input to dopaminergic neurons. Local downregulation of Crh mRNA and specific pharmacological blockade of CRF1 receptors in the VTA reversed the effect of nicotine on GABAergic input to dopaminergic neurons, prevented the aversive effects of nicotine withdrawal and limited the escalation of nicotine intake. These results link the brain reward and stress systems in the same brain region to signaling of the negative motivational effects of nicotine withdrawal.
Mots clés
Animals, Corticotropin-Releasing Hormone, physiology, Humans, Inhibitory Postsynaptic Potentials, drug effects, Male, Mice, Mice, Inbred C57BL, Neurons, drug effects, Nicotine, adverse effects, Organ Culture Techniques, Rats, Rats, Wistar, Substance Withdrawal Syndrome, metabolism, Ventral Tegmental Area, drug effects
Référence
Nat. Neurosci.. 2014 Dec;17(12):1751-8